跳至主要内容
临床试验/NCT04245592
NCT04245592Unknown不适用

Fibromyalgia and Oxidative Stress. Influence of the Olive Oil Consumption

University of Jaén2 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2020年1月15日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
24
试验地点
2
主要终点
Fibrinogen

研究概览

简要总结

We have recently reported a prothrombotic state in patients with fibromyalgia that may increase the risk of thrombosis-related cardiovascular disease in these patients. Several studies have shown the cardioprotective, antithrombotic and antiinflammatory properties of olive oil. The objective of the study is to investigate the effect of consumption of two types of olive oils with different antioxidant content on thrombosis-related parameters, nitric oxide, inflammation, lipid profile and cortisol as well as on health-related parameters in women with fibromyalgia.

详细描述

Aim:

The goal of the present study is to investigate the effects of two olive oils with different antioxidant content on cardiovascular risk factors (blood-coagulation parameters, platelet indices, red blood cell count, inflammatory markers, lipid profile, nitric oxide and cortisol) in patients diagnosed with fibromyalgia. The investigators will determine thrombosis-related parameters (fibrinogen levels, prothrombin time, prothrombin activity, cephaline time, platelet count, platelet distribution width [PDW], mean platelet volume [MPV], plateletcrit, red blood cell [RBC] count, neutrophil-to-lymphocyte ratio [NLR], and platelet-to-lymphocyte ratio [PLR]), inflammatory markers (interleukin 6 [IL-6], IL-10, C-reactive protein [CRP], erythrocyte sedimentation rate (ESR)), nitric oxide levels, lipid profile, and cortisol levels.

Participants:

This study will be carry out in accordance with the provisions of the Declaration of Helsinki of the World Medical Association.

The research group will contact a Spanish association of patients with fibromyalgia, AFIXA (Association of Fibromyalgia of Jaén, Spain) to find patients to participate in the study. The researchers will convene patients in the laboratory of the Faculty of Health Sciences of the University of Jaén (Spain) to obtain several data of interest (age, BMI, other chronic diseases, pregnancy, lactation and medication). Based on these data, the investigators will select the fibromyalgia group. In a second visit to the laboratory, all patients will sign an informed consent form, the blood samples will be taken and the they will complete several questionnaires (Fibromyalgia Impact Questionnaire, Visual Analogic Scale, Short Form 12 Health Survey).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Double (Participant, Investigator)

盲法说明

Patients were blinded to the kind of olive oil consumed using unlabeled bottles.

A coding number in the blood samples of the patients were used to blind the Investigators.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with fibromyalgia will be previously diagnosed with fibromyalgia by a professional rheumatologist and met the American College of Rheumatology (ACR) criteria for fibromyalgia.

排除标准

  • Presence of any other chronic disease (diabetes mellitus, hypertension, rheumatoid arthritis, hepatitis, cancer or ischemic heart disease)
  • Dyslipidemia
  • Pregnancy
  • Lactation
  • Grade II obesity (BMI ≥ 35 kg/m2)
  • Under anticoagulant, corticosteroid, estrogen, analgesic or anti-inflammatory treatment (or they have stopped using them at least 2 months before the start of our study).).
  • Patients who consume alcohol regularly

结局指标

主要结局

Fibrinogen

时间窗: 2 weeks

Will be determined in plasma samples using the BCS XP analyzer (Siemens Healthineers, Erlangen, Germany).

Platelet count

时间窗: 2 weeks

Will be measured in plasma samples by flow cytometry using the ADVIA 2120 analyzer (Siemens Healthineers, Erlangen, Germany).

Mean platelet volume [MPV]

时间窗: 2 weeks

Will be measured in plasma samples by flow cytometry using the ADVIA 2120 analyzer (Siemens Healthineers, Erlangen, Germany).

IL-6

时间窗: 2 weeks

Interleukin 6 will be analyzed by chemiluminescent immunoassay using the Access Immunoassay Systems (Beckman Coulter)

Lipid Profile

时间窗: 2 weeks

Serum lipid profile (total cholesterol, high-density lipoprotein \[HDL\]-cholesterol, triglycerides, apolipoprotein A1, and apolipoprotein B) will be measured by a spectrophotometric procedure using an OLYMPUS AU 5400 analyzer (Beckman Coulter). Low-density lipoprotein (LDL)-cholesterol levels will be estimated indirectly with the Friedewald equation. The level of homocysteine will be determined by a fluorescence polarization immunoassay using an AxSYM analyzer (Abbott Laboratories)

Red blood cell (RBC)

时间窗: 2 weeks

Will be measured in plasma samples by flow cytometry using the ADVIA 2120 analyzer (Siemens Healthineers, Erlangen, Germany).

Neutrophil count

时间窗: 2 weeks

Will be measured in plasma samples by flow cytometry using the ADVIA 2120 analyzer (Siemens Healthineers, Erlangen, Germany).

Lymphocyte counts

时间窗: 2 weeks

Will be measured in plasma samples by flow cytometry using the ADVIA 2120 analyzer (Siemens Healthineers, Erlangen, Germany).

Lipid peroxidation

时间窗: 2 weeks

Quantitation of thiobarbituric acid reactive substances (TBARS) presence

Prothrombin activity

时间窗: 2 weeks

Will be determined in plasma samples using the BCS XP analyzer (Siemens Healthineers, Erlangen, Germany).

Cephaline time

时间窗: 2 weeks

Will be determined in plasma samples using the BCS XP analyzer (Siemens Healthineers, Erlangen, Germany).

Nitric Oxide

时间窗: 4 weeks

NO production will be indirectly quantified by measuring nitrate/nitrite and S-nitrose compounds (NOx) using an ozone chemiluminescence-based method.

Cortisol

时间窗: 2 weeks

Cortisol level will be determined in serum samples by a fluorescence polarization immunoassay using an AxSYM analyser

IL-10

时间窗: 2 weeks

Levels of IL-10 will be measured by a chemiluminescent immunoenzymatic assay using an MLX™ luminometer (Dynex Technologies, Chantilly, VA).

C-Reactive Protein

时间窗: 2 weeks

CRP will be measured using an AU 5800 analyzer (Beckman Coulter).

Platelet distribution width [PDW]

时间窗: 2 weeks

Will be measured in plasma samples by flow cytometry using the ADVIA 2120 analyzer (Siemens Healthineers, Erlangen, Germany).

次要结局

未报告次要终点

研究者

发起方
University of Jaén
申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco Molina Ortega

Associate professor

University of Jaén

研究点 (2)

Loading locations...

相似试验